TACSTD2 and breast carcinoma: Over a 32-month period, we collected and enumerated Trop2+ (T2CTCs) and cCTCs from the blood of breast cancer patients of all subtypes, covering diverse treatment regimens, stages, and lines of metastatic therapy.